Mark Pearson - 13 Feb 2025 Form 4 Insider Report for Equitable Holdings, Inc. (EQH)

Role: President and CEO, Director
Signature: /s/ Michael Brudoley as attorney-in-fact for Mark Pearson
Issuer symbol: EQH
Transactions as of: 13 Feb 2025
Net transaction value: -$1,193,654
Form type: 4
Filing time: 18 Feb 2025, 17:36:24 UTC
Previous filing: 16 Jan 2025
Next filing: 04 Mar 2025
SEC filing: View on sec.gov

Key filing fact

Mark Pearson filed Form 4 for Equitable Holdings, Inc. (EQH) on 18 Feb 2025.

Key facts

This page summarizes Mark Pearson's Form 4 filing for Equitable Holdings, Inc. (EQH).
8 reported transactions and 1 derivative row are listed below.
Filing timestamp: 18 Feb 2025, 17:36.

Change

Previous filing in this sequence was filed on 16 Jan 2025.
Current net transaction value: -$1,193,654.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

EQH transaction

Common Stock

Award

Transaction value: $0
Shares: +94,524
Change %: +15%
Price: $0.000000
Shares after: 724,463
Date: 13 Feb 2025
Ownership: Direct
Footnotes: F1, F2

EQH transaction

Common Stock

Options Exercise

Transaction value: $463,600
Shares: +20,000
Change %: +2.8%
Price: $23.18
Shares after: 744,463
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3

EQH transaction

Common Stock

Sale

Transaction value: $32,397
Shares: -600
Change %: -0.08%
Price: $53.99
Shares after: 743,863
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3, F4

EQH transaction

Common Stock

Sale

Transaction value: $1,066,908
Shares: -19,300
Change %: -2.6%
Price: $55.28
Shares after: 724,563
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3, F5

EQH transaction

Common Stock

Sale

Transaction value: $5,578
Shares: -100
Change %: -0.01%
Price: $55.78
Shares after: 724,463
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3

EQH transaction

Common Stock

Sale

Transaction value: $23,250
Shares: -429
Change %: -0.06%
Price: $54.20
Shares after: 724,034
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3, F6

EQH transaction

Common Stock

Sale

Transaction value: $529,122
Shares: -9,571
Change %: -1.3%
Price: $55.28
Shares after: 714,463
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F2, F3, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

EQH transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -20,000
Change %: -4.5%
Price: $0.000000
Shares after: 426,400
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $23.18
Footnotes: F8

^* indicates a reported price that failed the local validity check.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three ratable annual installments beginning on February 28, 2026. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
F2	Total includes Restricted Stock Units.
F3	The sales reported and options exercised on this Form 4 were effected pursuany to a 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
F4	This transaction was executed in multiple trades at prices ranging from $53.7450 to $54.7300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	This transaction was executed in multiple trades at prices ranging from $54.7600 to $55.7500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6	This transaction was executed in multiple trades at prices ranging from $53.8500 to $54.8200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7	This transaction was executed in multiple trades at prices ranging from $54.8800 to $55.7500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8	Grant of employee stock option uncer the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.